Chronic Inflammation Accelerates Heart Aging Through Reduced Heart Rate Variability

This terminated German clinical trial explored how lifelong inflammatory burden accelerates cardiac aging through reduced heart rate variability. Researchers investigated whether accumulated inflammatory stress from infections and immune responses throughout life contributes to age-related decline in heart function.

The study enrolled 96 participants to test fluvastatin's ability to reduce inflammatory markers and preserve heart rate variability. Heart rate variability naturally decreases with age and serves as a sensitive marker of cardiac aging and autonomic nervous system function. The researchers hypothesized that chronic inflammation drives this decline.

The trial examined the bidirectional relationship between inflammation and the autonomic nervous system. The vagus nerve can both respond to inflammatory signals and release anti-inflammatory compounds through the "cholinergic anti-inflammatory reflex." This mechanism helps localize inflammation and prevent systemic cytokine spillover.

Although terminated early, the study provided valuable insights into cardiac aging mechanisms. The research suggests that elevated inflammatory markers like CRP and IL-6 in elderly individuals reflect accumulated "pathogen burden" that compromises both immune function and cardiac health over time.

The findings have significant implications for longevity strategies. Managing inflammatory load throughout life through lifestyle interventions, medications, or other approaches may help preserve heart rate variability and slow cardiac aging. This could maintain cardiovascular reserve capacity and autonomic function into older age, potentially extending healthspan and reducing cardiovascular disease risk.